Early phase process scale-up challenges for fungal and filamentous bacterial cultures

被引:24
作者
Junker, BH
Hesse, M
Burgess, B
Masurekar, P
Connors, N
Seeley, A
机构
[1] Merck Res Labs, Fermentat Dev & Operat, Rahway, NJ 07065 USA
[2] Merck Res Labs, Human & Anim Infect Dis, Rahway, NJ 07065 USA
关键词
morphology; pellet; fermentation; scale-up; Aspergillus; Sordaria; Streptomyces; Chalara;
D O I
10.1007/s12010-004-0005-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Culture pelleting and morphology has a strong influence on process productivity and success for fungal and filamentous bacterial cultures. This impact is particularly evident with early phase secondary metabolite processes with limited process definition. A compilation of factors affecting filamentous or pelleting morphology described in the literature indicates potential leads for developing process-specific control methodologies. An evaluation of the factors mediating citric acid production is one example of an industrially important application of these techniques. For five model fungal and filamentous bacterial processes in an industrial fermentation pilot plant, process development strategies were developed and effectively implemented with the goal of achieving reasonable fermentation titers early in the process development cycle. Examples of approaches included the use of additives to minimize pelleting in inoculum shake flasks, the use of large-volume frozen bagged inoculum obtained from agitated seed fermentors, and variations in production medium composition and fermentor operating conditions. Results were evaluated with respect to productivity of desired secondary metabolites as well as process scalability. On-line measurements were utilized to indirectly evaluate the cultivation impact of changes in medium and process development. Key laboratory to pilot plant scale-up issues also were identified and often addressed in subsequent cultivations.
引用
收藏
页码:241 / 277
页数:37
相关论文
共 98 条
[1]  
[Anonymous], [No title captured], Patent No. [US 5350763, 5350763]
[2]  
Archer DB, 1995, APPL MICROBIOL BIOT, V44, P157, DOI 10.1007/s002530050534
[3]   From natural products to clinically useful antifungals [J].
Barrett, D .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3) :224-233
[4]   MORPHOLOGY AND CLAVULANIC ACID PRODUCTION OF STREPTOMYCES-CLAVULIGERUS - EFFECT OF STIRRER SPEED IN BATCH FERMENTATIONS [J].
BELMARBEINY, MT ;
THOMAS, CR .
BIOTECHNOLOGY AND BIOENGINEERING, 1991, 37 (05) :456-462
[5]   SUBMERGED CITRIC-ACID FERMENTATION - RHEOLOGICAL PROPERTIES OF ASPERGILLUS-NIGER BROTH IN A STIRRED TANK REACTOR [J].
BEROVIC, M ;
CIMERMAN, A ;
STEINER, W ;
KOLOINI, T .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 1991, 34 (05) :579-581
[6]  
BILLS G, 1997, Patent No. 9811891
[7]   SODIUM GLUCONATE PRODUCTION - FERMENTATION WITH ASPERGILLUS NIGER [J].
BLOM, RH ;
PFEIFER, VF ;
MOYER, AJ ;
TRAUFLER, DH ;
CONWAY, HF ;
CROCKER, CK ;
FARISON, RE ;
HANNIBAL, DV .
INDUSTRIAL AND ENGINEERING CHEMISTRY, 1952, 44 (02) :435-440
[8]   MYCELIAL MORPHOLOGY AND METABOLITE PRODUCTION [J].
BRAUN, S ;
VECHTLIFSHITZ, SE .
TRENDS IN BIOTECHNOLOGY, 1991, 9 (02) :63-68
[9]  
BUCKLAND B, 1985, BIO-TECHNOL, V3, P982, DOI 10.1038/nbt1185-982
[10]  
BUJALSKI W, 1997, BHR GROUP C SERIES P, V25, P9